Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients.
Davey RT Jr, Chaitt DG, Reed GF, Freimuth WW, Herpin BR, Metcalf JA, Eastman PS, Falloon J, Kovacs JA, Polis MA, Walker RE, Masur H, Boyle J, Coleman S, Cox SR, Wathen L, Daenzer CL, Lane HC. Davey RT Jr, et al. Among authors: wathen l. Antimicrob Agents Chemother. 1996 Jul;40(7):1657-64. doi: 10.1128/AAC.40.7.1657. Antimicrob Agents Chemother. 1996. PMID: 8807058 Free PMC article. Clinical Trial.
Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patients.
Demeter LM, Meehan PM, Morse G, Fischl MA, Para M, Powderly W, Leedom J, Holden-Wiltse J, Greisberger C, Wood K, Timpone J Jr, Wathen LK, Nevin T, Resnick L, Batts DH, Reichman RC. Demeter LM, et al. Among authors: wathen lk. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):135-44. doi: 10.1097/00042560-199810010-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9768622 Clinical Trial.
Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen.
Gilliam BL, Dyer JR, Fiscus SA, Marcus C, Zhou S, Wathen L, Freimuth WW, Cohen MS, Eron JJ Jr. Gilliam BL, et al. Among authors: wathen l. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 1;15(1):54-60. doi: 10.1097/00042560-199705010-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9215655 Clinical Trial.
Validation of a quantitative RNA PCR assay for HIV-1 in human plasma.
Wathen LK, Crampton DJ, Patel RK, Nuorala KW, Poppe SM, Dueweke TJ, Re' KA, Krieger KS, Tarpley WG. Wathen LK, et al. J Clin Lab Anal. 1996;10(5):262-8. doi: 10.1002/(SICI)1098-2825(1996)10:5<262::AID-JCLA6>3.0.CO;2-A. J Clin Lab Anal. 1996. PMID: 8887005
Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival.
Minga I, Kwak E, Hussain K, Wathen L, Gaznabi S, Singh L, Macrinici V, Wang CH, Singulane C, Addetia K, Sarswat N, Slivnick J, Pursnani A. Minga I, et al. Among authors: wathen l. Curr Probl Cardiol. 2024 Apr;49(4):102417. doi: 10.1016/j.cpcardiol.2024.102417. Epub 2024 Jan 25. Curr Probl Cardiol. 2024. PMID: 38280494 Review.
Impact of Tafamidis on Survival in a Real-World Community-Based Cohort.
Hussain K, Macrinici V, Wathen L, Balasubramanian SS, Minga I, Gaznabi S, Kwak E, Wang CH, Iqbal SH, Pursnani A, Sarswat N. Hussain K, et al. Among authors: wathen l. Curr Probl Cardiol. 2022 Dec;47(12):101358. doi: 10.1016/j.cpcardiol.2022.101358. Epub 2022 Aug 19. Curr Probl Cardiol. 2022. PMID: 35995245 Review.
31 results